Despite low volatility in the domestic stock markets over the past few months, investors are expected to tread cautiously ...

Domestic brokerage Nuvama Institutional Equities warned that Nifty 50's decline is due to weak earnings and high valuations, ...

Given the persistent selling by global funds, Nifty recorded five consecutive months of selling - the first time in three ...

India’s earnings are reconciling with not just weak top-line growth, but also its EM peers. High valuation only added to the ...

Citi's picks in India's asset management companies are 360 One, Nuvama and Prudent. While Aditya Birla Sun Life AMC Ltd's ...

While the central bank's easing measures may provide short-term relief, global uncertainties—such as a US growth slowdown and ...

Nuvama is of the view that the Zydus Life's latest deal would be dilutive to the company's Earnings Per Share (EPS) by 1% to ...

Brokerages deemed Zydus Life's acquisition of Amplitude Surgical as expensive, with subpar synergies that has triggered ...

Nuvama cuts Zydus Lifesciences target by 16%, citing weak synergy with Amplitude acquisition. Read more about the financial outlook now!

Explore ACME Solar's growth potential; analysts predict a 70% upside. Diversifying into nuclear energy and boosting capacity.

Shares of Zee Entertainment rose on Friday after brokerage house Nuvama maintained a 'buy' rating with a target price of Rs ...

Nuvama Institutional Equities has kept its 'Buy' rating on BSE Ltd intact amid what it called the futures and options (F&O) expiry war with peer NSE. The brokerage has, however, cut its target ...